These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
589 related articles for article (PubMed ID: 8402635)
1. Main drug- and carcinogen-metabolizing enzyme systems in human non-small cell lung cancer and peritumoral tissues. Toussaint C; Albin N; Massaad L; Grunenwald D; Parise O; Morizet J; Gouyette A; Chabot GG Cancer Res; 1993 Oct; 53(19):4608-12. PubMed ID: 8402635 [TBL] [Abstract][Full Text] [Related]
2. Main drug-metabolizing enzyme systems in human breast tumors and peritumoral tissues. Albin N; Massaad L; Toussaint C; Mathieu MC; Morizet J; Parise O; Gouyette A; Chabot GG Cancer Res; 1993 Aug; 53(15):3541-6. PubMed ID: 8339260 [TBL] [Abstract][Full Text] [Related]
3. Comparison of mouse and human colon tumors with regard to phase I and phase II drug-metabolizing enzyme systems. Massaad L; de Waziers I; Ribrag V; Janot F; Beaune PH; Morizet J; Gouyette A; Chabot GG Cancer Res; 1992 Dec; 52(23):6567-75. PubMed ID: 1423302 [TBL] [Abstract][Full Text] [Related]
4. [Screening of principal enzymes involved in the metabolism of anticancer drugs in human and murine colonic tumors]. Massaad L; de Waziers I; Ribrag V; Janot F; Morizet J; Beaune PH; Gouyette A; Chabot GG Bull Cancer; 1993 May; 80(5):397-407. PubMed ID: 8173193 [TBL] [Abstract][Full Text] [Related]
5. Principal xenobiotic-metabolizing enzyme systems in human head and neck squamous cell carcinoma. Janot F; Massaad L; Ribrag V; de Waziers I; Beaune PH; Luboinski B; Parise O; Gouyette A; Chabot GG Carcinogenesis; 1993 Jul; 14(7):1279-83. PubMed ID: 8330340 [TBL] [Abstract][Full Text] [Related]
6. Principal drug-metabolizing enzyme systems in L1210 leukemia sensitive or resistant to BCNU in vivo. Ribrag V; Massaad L; Janot F; Bissery MC; Parise O; Gouyette A; Chabot GG Leuk Res; 1994 Nov; 18(11):829-35. PubMed ID: 7967709 [TBL] [Abstract][Full Text] [Related]
7. Influence of tumor size on the main drug-metabolizing enzyme systems in mouse colon adenocarcinoma Co38. Massaad L; Chabot GG; Toussaint C; Koscielny S; Morizet J; Bissery MC; Gouyette A Cancer Chemother Pharmacol; 1994; 34(6):497-502. PubMed ID: 7923560 [TBL] [Abstract][Full Text] [Related]
8. Main drug-metabolizing enzyme systems in human non-Hodgkin's lymphomas sensitive or resistant to chemotherapy. Ribrag V; Massaad L; Janot F; Morizet J; Gouyette A; Chabot GG Leuk Lymphoma; 1995 Jul; 18(3-4):303-10. PubMed ID: 8535197 [TBL] [Abstract][Full Text] [Related]
9. Hepatic drug-metabolizing enzymes in primary and secondary tumors of human liver. el Mouelhi M; Didolkar MS; Elias EG; Guengerich FP; Kauffman FC Cancer Res; 1987 Jan; 47(2):460-6. PubMed ID: 3024821 [TBL] [Abstract][Full Text] [Related]
10. Long-lasting effects of tobacco smoking on pulmonary drug-metabolizing enzymes: a case-control study on lung cancer patients. Petruzzelli S; Camus AM; Carrozzi L; Ghelarducci L; Rindi M; Menconi G; Angeletti CA; Ahotupa M; Hietanen E; Aitio A Cancer Res; 1988 Aug; 48(16):4695-700. PubMed ID: 3135117 [TBL] [Abstract][Full Text] [Related]
11. The immunohistochemical localization of drug-metabolizing enzymes in prostate cancer. Murray GI; Taylor VE; McKay JA; Weaver RJ; Ewen SW; Melvin WT; Burke MD J Pathol; 1995 Oct; 177(2):147-52. PubMed ID: 7490681 [TBL] [Abstract][Full Text] [Related]
12. Expression of glutathione S-transferases in fetal lung and liver tissue from parental strains and F1 crosses between C57BL/6 and BALB/c F1 mice following in utero exposure to 3-methylcholanthrene. Xu M; Moore JE; Leone-Kabler S; McCoy TP; Swank A; Nelson GB; Ross JA; Townsend AJ; Miller MS Biochem Pharmacol; 2006 Jun; 72(1):115-23. PubMed ID: 16678797 [TBL] [Abstract][Full Text] [Related]
13. Phase I and phase II drug-metabolizing enzymes are expressed and heterogeneously distributed in the biliary epithelium. Lakehal F; Wendum D; Barbu V; Becquemont L; Poupon R; Balladur P; Hannoun L; Ballet F; Beaune PH; Housset C Hepatology; 1999 Dec; 30(6):1498-506. PubMed ID: 10573530 [TBL] [Abstract][Full Text] [Related]
14. Tissue distribution of drug-metabolizing enzymes in humans. Pacifici GM; Franchi M; Bencini C; Repetti F; Di Lascio N; Muraro GB Xenobiotica; 1988 Jul; 18(7):849-56. PubMed ID: 3140501 [TBL] [Abstract][Full Text] [Related]
15. Cytochrome p450 and glutathione transferase expression in squamous cell cancer. Ali S; El-Rayes BF; Heilbrun LK; Sarkar FH; Ensley JF; Kucuk O; Philip PA Clin Cancer Res; 2004 Jul; 10(13):4412-6. PubMed ID: 15240530 [TBL] [Abstract][Full Text] [Related]
16. Expression of glutathione S-transferase M2 in stage I/II non-small cell lung cancer and alleviation of DNA damage exposure to benzo[a]pyrene. Tang SC; Sheu GT; Wong RH; Huang CY; Weng MW; Lee LW; Hsu CP; Ko JL Toxicol Lett; 2010 Feb; 192(3):316-23. PubMed ID: 19900515 [TBL] [Abstract][Full Text] [Related]
17. Effect of dietary supplementation with carotenoids on xenobiotic metabolizing enzymes in the liver, lung, kidney and small intestine of the rat. Jewell C; O'Brien NM Br J Nutr; 1999 Mar; 81(3):235-42. PubMed ID: 10434850 [TBL] [Abstract][Full Text] [Related]
18. Differences in the expression of xenobiotic-metabolizing enzymes between islets derived from the ventral and dorsal anlage of the pancreas. Standop J; Ulrich AB; Schneider MB; Büchler MW; Pour PM Pancreatology; 2002; 2(6):510-8. PubMed ID: 12435863 [TBL] [Abstract][Full Text] [Related]
19. Expression of glutathione S-transferase pi and glutathione synthase correlates with survival in early stage non-small cell carcinomas of the lung. Allen TC; Granville LA; Cagle PT; Haque A; Zander DS; Barrios R Hum Pathol; 2007 Feb; 38(2):220-7. PubMed ID: 17234469 [TBL] [Abstract][Full Text] [Related]
20. [Immunohistochemical investigation on the expression of glutathione S-transferases (GSTS) in lung cancer]. Nie KR; Li CH; Zhu YJ Zhonghua Jie He He Hu Xi Za Zhi; 1993 Jun; 16(3):141-3, 186. PubMed ID: 8242809 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]